As of 2025-09-15, the EV/EBITDA ratio of Health Catalyst Inc (HCAT) is -62.89. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. HCAT's latest enterprise value is 322.57 mil USD. HCAT's TTM EBITDA according to its financial statements is -5.13 mil USD. Dividing these 2 quantities gives us the above HCAT EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 8.2x - 14.5x | 10.6x |
| Forward P/E multiples | 10.6x - 18.5x | 16.2x |
| Fair Price | (2.23) - (2.51) | (2.43) |
| Upside | -171.2% - -180.1% | -177.7% |
| Date | EV/EBITDA |
| 2025-09-12 | -62.89 |
| 2025-09-11 | -64.40 |
| 2025-09-10 | -64.68 |
| 2025-09-09 | -66.60 |
| 2025-09-08 | -66.32 |
| 2025-09-05 | -66.32 |
| 2025-09-04 | -65.22 |
| 2025-09-03 | -64.40 |
| 2025-09-02 | -66.60 |
| 2025-08-29 | -66.46 |
| 2025-08-28 | -70.03 |
| 2025-08-27 | -70.58 |
| 2025-08-26 | -67.97 |
| 2025-08-25 | -65.77 |
| 2025-08-22 | -64.95 |
| 2025-08-21 | -61.93 |
| 2025-08-20 | -60.01 |
| 2025-08-19 | -61.11 |
| 2025-08-18 | -61.11 |
| 2025-08-15 | -60.01 |
| 2025-08-14 | -60.08 |
| 2025-08-13 | -64.13 |
| 2025-08-12 | -61.11 |
| 2025-08-11 | -56.99 |
| 2025-08-08 | -58.78 |
| 2025-08-07 | -70.58 |
| 2025-08-06 | -72.36 |
| 2025-08-05 | -72.36 |
| 2025-08-04 | -69.75 |
| 2025-08-01 | -68.24 |
| 2025-07-31 | -70.03 |
| 2025-07-30 | -70.44 |
| 2025-07-29 | -73.73 |
| 2025-07-28 | -76.06 |
| 2025-07-25 | -73.18 |
| 2025-07-24 | -72.77 |
| 2025-07-23 | -75.51 |
| 2025-07-22 | -74.01 |
| 2025-07-21 | -73.05 |
| 2025-07-18 | -70.03 |
| 2025-07-17 | -71.40 |
| 2025-07-16 | -71.95 |
| 2025-07-15 | -71.26 |
| 2025-07-14 | -72.91 |
| 2025-07-11 | -73.32 |
| 2025-07-10 | -74.69 |
| 2025-07-09 | -75.24 |
| 2025-07-08 | -75.38 |
| 2025-07-07 | -74.14 |
| 2025-07-03 | -75.65 |